(Q38176854)

30 August 2017

title

Isolated limb perfusion for in-transit melanoma metastases: melphalan or TNF-melphalan perfusion? (English)

1 reference

30 August 2017

0 references

Harald J Hoekstra

1

1 reference

30 August 2017

Kelly Veerman

series ordinal

2

1 reference

30 August 2017

Robert J van Ginkel

series ordinal

3

1 reference

30 August 2017

publication date

9 January 2014

1 reference

Journal of Surgical Oncology

30 August 2017

published in

1 reference

30 August 2017

volume

109

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

338-347

1 reference

Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients.

30 August 2017

cites work

1 reference

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database

21 January 2018

1 reference

Risk factors associated with local and in-transit recurrence of cutaneous melanoma

21 January 2018

1 reference

Follow-up in patients with localised primary cutaneous melanoma

21 January 2018

1 reference

Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup

21 January 2018

1 reference

Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)

21 January 2018

1 reference

Stage IV melanoma: completely resectable patients are scarce.

21 January 2018

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

Improved survival with MEK inhibition in BRAF-mutated melanoma

21 January 2018

1 reference

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

21 January 2018

1 reference

Isolated limb perfusion with melphalan for melanoma

21 January 2018

1 reference

Outcomes following isolated limb infusion for melanoma. A 14-year experience

21 January 2018

1 reference

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

21 January 2018

1 reference

Improved tissue perfusion during pressure-regulated hyperthermic regional isolated perfusion in dogs.

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

The European approach to in-transit melanoma lesions

21 January 2018

1 reference

Isolated limb infusion: a review

21 January 2018

1 reference

The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanoma

21 January 2018

1 reference

Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma

21 January 2018

1 reference

Isolated limb perfusion of soft tissue sarcomas: a comprehensive review of literature

21 January 2018

1 reference

Septic shock: pathogenesis

21 January 2018

1 reference

Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study

21 January 2018

1 reference

High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan.

21 January 2018

1 reference

One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases

21 January 2018

1 reference

20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters

21 January 2018

1 reference

Regional therapy of melanoma

21 January 2018

1 reference

Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters

21 January 2018

1 reference

Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23552

1 reference

release_lcvbyg545fdhznom4asbermpia

30 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lcvbyg545fdhznom4asbermpia

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference